Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company has hit a new 52-week low, reflecting significant volatility and a decline of 18.56% over the past nine trading days. The stock is underperforming its sector and has dropped 63.77% in the past year, indicating ongoing challenges in its market position.

Sun Pharma Advanced Research Company has reached a new 52-week low, reflecting significant volatility and underperformance compared to its sector. The stock has declined consistently over the past eight days, with a notable drop over the past year, contrasting sharply with broader market gains.

Sun Pharma Advanced Research Company has faced notable stock volatility, nearing its 52-week low and experiencing an 11% decline over the past week. The stock is trading below all key moving averages and has seen a significant year-over-year performance drop of 58.40%, contrasting with the Sensex's gains.

Sun Pharma Advanced Research Company has hit a new 52-week low, reflecting significant volatility and an 8.81% decline over the past five days. The stock has underperformed its sector and is trading below its moving averages, with a notable 57.91% drop over the past year.

Sun Pharma Advanced Research Company (SPARC) has released its financial results for the quarter ending December 2024, showcasing its highest quarterly operating profit in five quarters. Despite improvements in operational metrics, the company faces challenges, including a significant rise in interest costs and a decline in net sales year on year.

Sun Pharma Advanced Research Company (SPARC) has released its financial results for the quarter ending December 2024, showcasing its highest quarterly operating profit in five quarters. Despite improvements in operational metrics, the company faces challenges, including a significant rise in interest costs and a decline in net sales year on year.

Sun Pharma Advanced Research Company has reached a new 52-week low, reflecting ongoing volatility and a consistent decline over the past four days. The stock has significantly underperformed its sector and is trading below key moving averages, indicating a challenging year with a notable decrease compared to the broader market.

Sun Pharma Advanced Research Company has hit a new 52-week low, continuing a downward trend with a significant decline over the past week. The stock is trading below all key moving averages and has faced a substantial year-over-year performance drop, contrasting with the overall market's gains.

Sun Pharma Advanced Research Company has hit a new 52-week low of Rs. 158, reflecting a significant decline over the past year, with a 57.09% drop. The stock has consistently underperformed its sector and is currently trading below all major moving averages, indicating ongoing challenges in the pharmaceuticals industry.

Sun Pharma Advanced Research Company has reached a new 52-week low, reflecting significant volatility and a decline of 8.82% over the past three days. The stock is trading below multiple moving averages and has dropped 56.65% over the past year, contrasting with the overall market's positive performance.

Sun Pharma Advanced Research Company has reached a new 52-week low, reflecting significant volatility and a notable downturn for the midcap pharmaceutical firm. The stock has declined consecutively over two days and is trading below multiple moving averages, indicating a bearish trend amid a challenging market environment.

Sun Pharma Advanced Research Company has reached a new 52-week low, reflecting significant underperformance compared to its sector. The stock is trading below all key moving averages and has experienced a substantial decline over the past year, contrasting sharply with the overall market's positive performance.

Sun Pharma Advanced Research Company (SPARC) experienced a difficult trading day on January 13, 2025, with its stock hitting a new 52-week low. The company has seen a significant cumulative decline over the past four days, underperforming the broader sector and the Sensex, indicating ongoing market challenges.

Sun Pharma Advanced Research Company (SPARC) has reached a new 52-week low, reflecting a broader trend of underperformance. Over the past year, the stock has declined significantly, contrasting sharply with the Sensex's gains. It is currently trading below multiple moving averages, indicating ongoing market challenges.

Sun Pharma Advanced Research Company has experienced a notable adjustment in its evaluation, reflecting ongoing challenges in its market performance. The stock recently reached a new 52-week low and has been added to MarketsMOJO's list, highlighting concerns over its significant decline over the past year compared to broader market trends.

Sun Pharma Advanced Research Company (SPARC) has recently seen a revision in its score, reflecting ongoing challenges in the pharmaceuticals sector. The stock has reached a new 52-week low and has been added to MarketsMOJO's list, highlighting its significant underperformance compared to the broader market.

Sun Pharma Advanced Research Company has recently undergone a revision in its score following a challenging trading session, where it closed down significantly and underperformed the broader market. The stock's persistent decline and trading below moving averages raise concerns, especially as it hovers near its 52-week low. It has been added to MarketsMOJO's list, prompting attention from investors.

Sun Pharma Advanced Research Company has seen a revision in its score following a notable price increase on December 16, 2024. The stock outperformed its sector and has been added to MarketsMOJO's list, reflecting its strong recent performance and positive market indicators despite its current evaluation.

Sun Pharma Advanced Research Company has seen a revision in its score following notable gains in its stock price on December 16, 2024. The stock's performance has improved significantly, surpassing sector trends and demonstrating strong momentum. Additionally, it has been added to MarketsMOJO's list, reflecting its enhanced market position.